Work

Alemtuzumab and Rituximab for Therapy of Patents with Early Stage High Risk CLL: Report of a Planned Interim Analysis.

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.2829.2829

Authors: Clive S. Zent, Nancy D. Bone, Timothy G. Call, Tait D. Shanafelt, Susan M. Geyer, Charla R. Secreto, Diane F. Jelinek, Gordon W. Dewald, Neil E. Kay

Institution: Mayo Clinic

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2556581702

FWCI: 0.583

Cites:

Cited by: 4

Related to: 10